Hypogonadal bone loss: Sex steroids or gonadotropins?

Endocrinology

Volumn 148, Issue 6, 2007, Pages 2610-2612

  Williams, Graham R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; FOLLITROPIN; GONADOTROPIN; SEX HORMONE; TESTOSTERONE;

BONE DENSITY; DISEASE MODEL; ENDOCRINOLOGY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; KYPHOSIS; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; OVARY FUNCTION; PHENOTYPE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; BONE RESORPTION; FEMALE; GONADAL STEROID HORMONES; GONADOTROPINS; HUMANS; HYPOGONADISM; MICE; MICE, KNOCKOUT; OSTEOPOROSIS, POSTMENOPAUSAL; RECEPTORS, FSH;

EID: 34250887411     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0337     Document Type: Short Survey

References (30)

1. Riggs BL, Khosla S, Melton LJ 2002 Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302
2. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi, M 2006 FSH directly regulates bone mass. Cell 125:247-260
3. Martin TJ, Gaddy D 2006 Bone loss goes beyond estrogen. Nat Med 12:612-613
4. Prior JC 2007 FSH and bone-important physiology or not? Trends Mol Med 13:1-3
5. Seibel MJ, Dunstan CR, Zhou H, Allan CM, Handelsman DJ 2006 Sex steroids, not FSH, influence bone mass. Cell 127:1079; author reply 1080-1081
6. Baron R 2006 FSH versus estrogen: who's guilty of breaking bones? Cell Metab 3:302-305
7. Zaidi M, Sun L, Kumar TR, Sairam MR, Blair HC 2006 Both FSH and sex steroid influence bone mass. Cell 127:180-181
8. Gao J, Tiwari-Pandey R, Samadfam R, Yang Y, Miao D, Karaplis AC, Sairam MR, Goltzman D 2007 Altered ovarian function affects skeletal homeostasis independent of the action of follicle-stimulating hormone. Endocrinology 148:2613-2621
9. Mason AJ, Hayflick JS, Zoeller RT, Young WS, Phillips HS, Nikolics K, Seeburg PH 1986 A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 234:1366-1371
10. Cattanach BM, Iddon CA, Charlton HM, Chiappa SA, Fink G 1977 Gonadotrophin-releasing hormone deficiency in a mutant mouse with hypogonadism. Nature 269:338-340
11. Sims NA, Brennan K, Spaliviero J, Handelsman DJ, Seibel MJ 2006 Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. Am J Physiol Endocrinol Metab 290:E456-E462
12. Rajendren G, Zhou H, Moonga BS, Zaidi M, Sun L 2006 Restoration of bone mass in hpg mouse by preoptic area grafting. Ann NY Acad Sci 1068:341-347
13. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR 2000 Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141:4295-4308
14. Balla A, Danilovich N, Yang Y, Sairam MR 2003 Dynamics of ovarian development in the FORKO immature mouse: structural and functional implications for ovarian reserve. Biol Reprod 69:1281-1293
15. Abel MH, Huhtaniemi I, Pakarinen P, Kumar TR, Charlton HM 2003 Age-related uterine and ovarian hypertrophy in FSH receptor knockout and FSHβ subunit knockout mice. Reproduction 125:165-173
16. Danilovich N, Javeshghani D, Xing W, Sairam MR 2002 Endocrine alterations and signaling changes associated with declining ovarian function and advanced biological aging in follicle-stimulating hormone receptor haploinsufficient mice. Biol Reprod 67:370-378
17. Prior JC 1998 Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 19:397-428
18. Sims NA, Clement-Lacroix P, Minet D, Fraslon-Vanhulle C, Gaillard-Kelly M, Resche-Rigon M, Baron R 2003 A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J Clin Invest 111:1319-1327
19. Couse JF, Yates MM, Walker VR, Korach KS 2003 Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) Null mice reveals hypergonadism and endocrine sex reversal in females lacking ERα but not ERβ. Mol Endocrinol 17:1039-1053
20. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061
21. Herrmann BL, Saller B, Janssen OE, Gocke P, Bockisch A, Sperling H, Mann K, Broecker M 2002 Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 87:5476-5484
22. Oz OK, Zerwekh JE, Fisher C, Graves K, Nanu L, Millsaps R, Simpson ER 2000 Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res 15:507-514
23. Oz OK, Hirasawa G, Lawson J, Nanu L, Constantinescu A, Antich PP, Mason RP, Tsyganov E, Parkey RW, Zerwekh JE, Simpson ER 2001 Bone phenotype of the aromatase deficient mouse. J Steroid Biochem Mol Biol 79:49-59
24. Miyaura C, Toda K, Inada M, Ohshiba T, Matsumoto C, Okada T, Ito M, Shizuta Y, Ito A 2001 Sex- and age-related response to aromatase deficiency in bone. Biochem Biophys Res Commun 280:1062-1068
25. Iqbal J, Sun L, Kumar TR, Blair HC, Zaidi M 2006 Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA 103:14925-14930
26. Welt CK 2004 Regulation and function of inhibins in the normal menstrual cycle. Semin Reprod Med 22:187-193
27. McNeilly AS, Crawford JL, Taragnat C, Nicol L, McNeilly JR 2003 The differential secretion of FSH and LH: regulation through genes, feedback and packaging. Reprod Suppl 61:463-476
28. Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC 2002 Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology 143:74-83
29. Perrien DS, Achenbach SJ, Bledsoe SE, Walser B, Suva LJ, Khosla S, Gaddy D 2006 Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab 91:1848-1854
30. Perrien DS, Akel NS, Edwards PK, Carver AA, Bendre MS, Swain FL, Skinner RA, Hogue WR, Nicks KM, Pierson TM, Suva LJ, Gaddy D 2007 Inhibin A is an endocrine stimulator of bone mass and strength. Endocrinology 148:1654-1665